Glaucoma not to blame for CCT decrease

Article

Central corneal thickness (CCT) may decrease over time, particularly in eyes with primary open angle glaucoma (POAG) but this may not be related to disease progression.

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
A person holds an Ozempic injector pen. Image credit: ©alones – stock.adobe.com

European Medicines Agency will assess semaglutide for link to NAION

Hattie Hayes
December 20th 2024
Article

The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the vision-threatening condition

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
July 22nd 2024
Podcast
An ophthalmologist uses a laser device in a lab, looking at the viewer. Image credit: ©Vadim – stock.adobe.com

A history of the femtosecond laser in the United States and Europe

Prof. H. Burkhard Dick
December 19th 2024
Article

The timeline demonstrates international innovation and collaboration

A picture of a scale on a laptop computer. One side of the scale holds a human brain, the other holds a laptop, symbolising artificial intelligence. Image credit: ©Who is Danny – stock.adobe.com

Balancing the promises and challenges of artificial intelligence

Polat Goktas, PhD;Andrzej Grzybowski, MD, PhD, MBA, MAE
December 18th 2024
Article

Sophisticated programmes require an evolving mindset

A person in a business suit holds a lit-up lightbulb. Image credit: ©kamiphotos – stock.adobe.com

EssilorLuxottica announces agreement for acquisition of Espansione Group

Sydney M Crago
December 17th 2024
Article

Espansione Group's Light Modulation Low-level Light Therapy (LLLT) is used in ophthalmology and dermatology

An image of a woman with irritated eyes. Image credit: ©Best – stock.adobe.com

A neurologist shares his warning about recurrent optic neuritis attacks and NMOSD

Hattie Hayes
December 17th 2024
Article

Ocular clues to a neurological conditions help clinicians understand neuromyelitis optica spectrum disorder (NMOSD)

© 2024 MJH Life Sciences

All rights reserved.